BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 17494072)

  • 1. The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription.
    Das AT; Harwig A; Vrolijk MM; Berkhout B
    J Virol; 2007 Jul; 81(14):7742-8. PubMed ID: 17494072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
    Rittner K; Churcher MJ; Gait MJ; Karn J
    J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
    Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
    Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression.
    Lisziewicz J; Rappaport J; Dhar R
    New Biol; 1991 Jan; 3(1):82-9. PubMed ID: 2039768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.
    Naryshkin NA; Gait MJ; Ivanovskaya MG
    Biochemistry (Mosc); 1998 May; 63(5):489-503. PubMed ID: 9632883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tat is required for efficient HIV-1 reverse transcription.
    Harrich D; Ulich C; García-Martínez LF; Gaynor RB
    EMBO J; 1997 Mar; 16(6):1224-35. PubMed ID: 9135139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
    Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E
    Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 tat trans-activation requires the loop sequence within tar.
    Feng S; Holland EC
    Nature; 1988 Jul; 334(6178):165-7. PubMed ID: 3386755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
    Kao SY; Calman AF; Luciw PA; Peterlin BM
    Nature; 1987 Dec 3-9; 330(6147):489-93. PubMed ID: 2825027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific interactions between HIV-1 nucleocapsid protein and the TAR element.
    Kanevsky I; Chaminade F; Ficheux D; Moumen A; Gorelick R; Negroni M; Darlix JL; Fossé P
    J Mol Biol; 2005 May; 348(5):1059-77. PubMed ID: 15854644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Tat in HIV-1 replication: an activator and/or a suppressor?
    Liang C; Wainberg MA
    AIDS Rev; 2002; 4(1):41-9. PubMed ID: 11998784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proximity of a Tat peptide to the HIV-1 TAR RNA loop region determined by site-specific photo-cross-linking.
    Wang Z; Huq I; Rana TM
    Bioconjug Chem; 1999; 10(3):512-9. PubMed ID: 10346885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-termination by SIV Tat requires flexibility of the nascent TAR structure.
    Sommer P; Vartanian JP; Wachsmuth M; Henry M; Guetard D; Wain-Hobson S
    J Mol Biol; 2004 Nov; 344(1):11-28. PubMed ID: 15504399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
    Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
    Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-sequence-mediated gene regulation in HIV-1.
    Cullen BR
    Infect Agents Dis; 1994; 3(2-3):68-76. PubMed ID: 7812657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling human immunodeficiency virus type 1 gene expression by unnatural peptides.
    Huq I; Ping YH; Tamilarasu N; Rana TM
    Biochemistry; 1999 Apr; 38(16):5172-7. PubMed ID: 10213623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA conformation in the Tat-TAR complex determined by site-specific photo-cross-linking.
    Wang Z; Rana TM
    Biochemistry; 1996 May; 35(20):6491-9. PubMed ID: 8639596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication.
    Verhoef K; Koper M; Berkhout B
    Virology; 1997 Oct; 237(2):228-36. PubMed ID: 9356335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.
    Rana TM; Jeang KT
    Arch Biochem Biophys; 1999 May; 365(2):175-85. PubMed ID: 10328810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.